跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Carbozaritine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Carbozaritine
Approved
STANDARD
Carbozaritine
Getwell Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f1255176f7d1c487
Company
Getwell Pharmaceuticals
Type
Standard
Approval Details
Approval Id
f1255176f7d1c487
Drug Approval Philippines Name
Carbozaritine
Product Name
Carbozaritine
Registration Number
DRP-5271-06
Brand Name
Carbozaritine
Generic Name
Carboplatin
Dosage Form
Solution for IV Infusion
Dosage Strength
10 mg/ mL (450 mg/ 45 mL)
Manufacturer
Getwell Pharmaceuticals
Importer
AGB Pharmaceutical Trading and Consultancy Corporation
Distributor
Oncotine Pharmaceutical Products Distribution
Issuance Date
24 March 2024
Expiry Date
16 April 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f1255176f7d1c487
Type
Standard
Back to Philippines FDA Approvals